Wexford Capital’s Lydall, Inc. LDL Stock Holding History

Wexford Capital’s Portfolio LDL Stock Details LDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-11,344	Closed	-$702K	–	267
2016 Q4	$702K	Buy	+11,344	New	+$627K	0.07%	91

Other funds holding LDL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Advisory Research Chicago, Illinois $813M AUM 36.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Wexford Capital's LDL Position: Q1 2017 in Review

Wexford Capital sold out of Lydall, Inc. (LDL) in Q1 2017, closing a stake of 11,344 shares — an estimated $702K sold.

Wexford Capital first reported a position in LDL in Q4 2016 and held it in 1 quarter. The position peaked at $702K in Q4 2016. 152 funds tracked by Wall St. Rank hold LDL as of Q1 2017.

Wexford Capital reported no remaining Lydall, Inc. position as of Q1 2017 after selling out during the quarter.
Wexford Capital sold 11,344 Lydall, Inc. shares in Q1 2017, an estimated $702K.
Wexford Capital first reported a position in Lydall, Inc. in Q4 2016 and held it in 1 quarter.
Wexford Capital's Lydall, Inc. position peaked at $702K in Q4 2016.
152 funds tracked by Wall St. Rank held Lydall, Inc. as of Q1 2017.

Based on Wexford Capital's 13F filing for Q1 2017, filed 12 May 2017.